Over the recent years, the treatment of multiple sclerosis (MS) and neuromyelitis optica
spectrum disorder (NMOSD) has evolved very rapidly and a large number of disease …

Abstract Purpose of Review Multiple sclerosis (MS) is a prevalent and debilitating
neuroinflammatory disease associated with a significant economic burden. Direct healthcare …

Background: Off-label disease-modifying therapies (DMTs) for multiple sclerosis (MS) are
used in at least 89 countries. There is a need for structured and transparent evidence-based …

Background Previous research has shown that cerebral T1 hypointense lesions are
positively correlated with the disability of multiple sclerosis (MS) patients. Hence, they could …

Sažetak Cilj istraživanja: Ispitati kako genetičke izmjene u miševima, konkretno u genima
St3Gal2, St3Gal3 i St3Gal2/3, utječu na ekspresiju markera povezanih s mijelinizacijom u …

Questa tesi di laurea magistrale, condotta in collaborazione con AISM (Associazione Italiana
Sclerosi Multipla) la sezione REHAB dell'Istituto Italiano di Tecnologia, esplora la …

Summary This Master's Thesis, conducted in collaboration with AISM (Associazione Italiana
Sclerosi Multipla) and the REHAB section of the Italian Institute of Technology, explores the …

Introduction. Impulse conduction in damaged central nervous system axons can fail as the
body temperature rises, because faster Na+ channel kinetics give rise to briefer action …

Background: Rituximab is a monoclonal antibody widely used in the treatment of
inflammatory and autoimmune disorders. Despite reports of its effectiveness in the treatment …

Background: Off-label disease-modifying therapies (DMTs) for multiple sclerosis (MS) are
used in at least 89 countries. There is a need for structured and transparent evidence-based …